JPWO2022196816A1 - - Google Patents

Info

Publication number
JPWO2022196816A1
JPWO2022196816A1 JP2023507207A JP2023507207A JPWO2022196816A1 JP WO2022196816 A1 JPWO2022196816 A1 JP WO2022196816A1 JP 2023507207 A JP2023507207 A JP 2023507207A JP 2023507207 A JP2023507207 A JP 2023507207A JP WO2022196816 A1 JPWO2022196816 A1 JP WO2022196816A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023507207A
Other languages
Japanese (ja)
Other versions
JPWO2022196816A5 (cg-RX-API-DMAC7.html
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022196816A1 publication Critical patent/JPWO2022196816A1/ja
Publication of JPWO2022196816A5 publication Critical patent/JPWO2022196816A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1271—Micrococcaceae (F); Staphylococcaceae (F), e.g. Staphylococcus (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6884—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/305—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F)
    • G01N2333/31—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Pulmonology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2023507207A 2021-03-19 2022-03-18 Pending JPWO2022196816A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021046301 2021-03-19
JP2021173381 2021-10-22
PCT/JP2022/012823 WO2022196816A1 (ja) 2021-03-19 2022-03-18 急性肺障害および肺線維症の急性増悪を改善するための医薬組成物

Publications (2)

Publication Number Publication Date
JPWO2022196816A1 true JPWO2022196816A1 (cg-RX-API-DMAC7.html) 2022-09-22
JPWO2022196816A5 JPWO2022196816A5 (cg-RX-API-DMAC7.html) 2025-03-26

Family

ID=83320552

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023507207A Pending JPWO2022196816A1 (cg-RX-API-DMAC7.html) 2021-03-19 2022-03-18

Country Status (8)

Country Link
US (1) US20260116957A1 (cg-RX-API-DMAC7.html)
EP (1) EP4310099A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2022196816A1 (cg-RX-API-DMAC7.html)
KR (1) KR20230171941A (cg-RX-API-DMAC7.html)
AU (1) AU2022239051A1 (cg-RX-API-DMAC7.html)
CA (1) CA3214262A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023010992A (cg-RX-API-DMAC7.html)
WO (1) WO2022196816A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116570716B (zh) * 2023-04-28 2025-05-16 水木星辰生物制药(深圳)有限公司 lncRNA LOC646762表达的抑制剂的应用和药物
CN117327147B (zh) * 2023-09-26 2024-05-10 广东海洋大学 一种抗急性肺损伤多肽及其应用
WO2026134246A1 (ja) * 2024-12-18 2026-06-25 国立大学法人三重大学 Corisin発現非ヒト動物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005247868A (ja) * 1996-10-31 2005-09-15 Chiron Srl 免疫原性の解毒変異体E.coliLT−A毒素
WO2020157222A1 (en) * 2019-01-30 2020-08-06 Ceva Sante Animale S.A. Inactivated apxia, apxiia and apxiiia toxins
WO2021126957A1 (en) * 2019-12-17 2021-06-24 Mie University Methods and compositions for evaluating and treating fibrosis

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014089209A2 (en) * 2012-12-04 2014-06-12 Abbvie, Inc. Blood-brain barrier (bbb) penetrating dual specific binding proteins
LT3071597T (lt) * 2013-11-21 2020-10-12 F. Hoffmann-La Roche Ag Antikūnai prieš alfa-sunukleiną ir jų naudojimo būdai
JP6394441B2 (ja) * 2014-04-07 2018-09-26 株式会社デンソー 内燃機関の冷却装置
US10280223B2 (en) * 2014-07-09 2019-05-07 Nippon Zenyaku Kogyo Co., Ltd. Anti-canine PD-1 antibody or anti-canine PD-L1 antibody
EP3380521A1 (en) * 2015-11-24 2018-10-03 Eli Lilly and Company Combination therapy for cancer
WO2017214456A1 (en) * 2016-06-08 2017-12-14 Abbvie Inc. Anti-cd98 antibodies and antibody drug conjugates
EP3678717B1 (en) * 2017-09-04 2026-07-08 Wockhardt Limited Autoinjector with a needle cover
EP3629024A1 (en) * 2018-09-26 2020-04-01 Assistance Publique - Hôpitaux de Marseille Cd146 and uses thereof as a biomarker and as a therapeutic target in the diagnosis and treatment of fibrosis
JP2021046301A (ja) 2019-09-19 2021-03-25 株式会社Screenホールディングス フィルムの剥離装置及び、フィルムの剥離方法
US11723926B2 (en) * 2019-09-27 2023-08-15 Starkage Therapeutics Senescent cell-associated antigen-binding domains, antibodies and chimeric antigen receptors comprising the same, and uses thereof
JP2021173381A (ja) 2020-04-28 2021-11-01 トヨタ自動車株式会社 ファンカップリング装置の制御装置

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005247868A (ja) * 1996-10-31 2005-09-15 Chiron Srl 免疫原性の解毒変異体E.coliLT−A毒素
WO2020157222A1 (en) * 2019-01-30 2020-08-06 Ceva Sante Animale S.A. Inactivated apxia, apxiia and apxiiia toxins
WO2021126957A1 (en) * 2019-12-17 2021-06-24 Mie University Methods and compositions for evaluating and treating fibrosis

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANTIMICROB. AGENTS CHEMOTHER., vol. 55, no. 1, JPN7022002480, 2011, pages 165 - 173, ISSN: 0005877114 *
INFECT. IMMUN., vol. 63, no. 6, JPN7022002481, 1995, pages 2356 - 2360, ISSN: 0005877112 *
NAT. COMMUN., vol. 11, no. 1539, JPN6022021620, 2020, pages 1 - 17, ISSN: 0005877111 *
SCI. REP., vol. 7, no. 8141, JPN6022021619, 2017, pages 1 - 11, ISSN: 0005877113 *

Also Published As

Publication number Publication date
US20260116957A1 (en) 2026-04-30
EP4310099A1 (en) 2024-01-24
AU2022239051A9 (en) 2023-10-26
MX2023010992A (es) 2023-11-14
AU2022239051A1 (en) 2023-10-12
WO2022196816A1 (ja) 2022-09-22
KR20230171941A (ko) 2023-12-21
CA3214262A1 (en) 2022-09-22
EP4310099A4 (en) 2025-09-17

Similar Documents

Publication Publication Date Title
CN306925456S (zh) 电视柜(2319)
CN306914352S (zh) 戒指(pafl1914921-wr)
CN306631138S (zh) 玩具陀螺车
CN306621817S (zh) 玩具摇铃(河马)
CN306749801S (zh) 花边(dea3691)
CN306912026S (zh) 酒柜(kt09302)
CN306657056S (zh) 凉鞋(一次成型儿童凉鞋)
CN306616600S (zh) 鞋底(zaq-093)
CN306652821S (zh) 台球桌桌腿(t09)
CN306666965S (zh) 鞋垫(爆米花硅胶全垫-后跟气囊)
CN306666244S (zh) 电子烟(c1)
CN306650621S (zh) 路灯灯头(智慧星)
CN306657730S (zh) 沙发(sf-9809)
CN306656276S (zh) 风扇灯(2021-001)
CN306628366S (zh) 花盆
CN306651945S (zh) 鞋底(黑)
CN306623062S (zh) 吊灯(硕果)
CN306653701S (zh) 包装盒(林下参)
CN306651782S (zh) 少女胸衣(067)
CN306672421S (zh) 斜流增压管道风机
CN306640346S (zh) 壁灯(镜前灯)
CN306670978S (zh) 带有多记录操作图形用户界面的手机
CN306673248S (zh) 吊灯(梵克雅宝-幸运tf1210d)
CN306605465S (zh) 硅胶手指套
CN306638573S (zh) 投影仪(w01)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250317

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250317

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260206

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260507

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260603